Sonoma Pharmaceuticals, Inc. — Director's Dealing 2007

Aug 15, 2007

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Oculus Innovative Sciences, Inc. (OCLS)
CIK: 0001367083
Period of Report: 2007-08-13

Reporting Person: Redhair Dana (Vice President)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2007-08-13	Stock Option (right to buy)	$8.46	A	50000	Acquired	2017-08-13	Common Stock (50000)	Direct

Footnotes

F1: The option vests as to 20% on the one year anniversary of grant and as to 1/60th each month thereafter.